GENinCode PLC - Result of Placing and Subscription
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR WITHIN
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF
GENinCode Plc
("GENinCode" or the "Company")
Result of Placing and Subscription
Further to the announcement made yesterday regarding a proposed placing, subscription and retail offer (the "Launch Announcement"), GENinCode plc (AIM: GENI) is pleased to announce that, it has conditionally raised gross proceeds of £3.9 million (before expenses) through the issue of an aggregate of 388,145,000 New Ordinary Shares under the Placing and Subscription, each at the Issue Price of 1 pence per share.
The Issue Price of
Cavendish, Oberon and
The Retail Offer was launched by way of a separate announcement at 5.26 p.m. on
Certain of the Company's Directors (the "Directors"), have either themselves or through parties affiliated with them subscribed for an aggregate of 23,000,000 New Ordinary Shares at the Issue Price as part of the Fundraising, as follows:
|
Name |
Number of existing Ordinary Shares |
Percentage of Existing Issued Share Capital |
Number of Subscription Shares allocated (1) |
Number of Ordinary Shares held following Admission |
Percentage of Enlarged Share Capital following Admission (2) |
|
|
14,737,636 |
5.14% |
500,000 |
15,237,636 |
2.1% |
|
|
12,235,473 |
4.26% |
2,000,000 |
14,235,473 |
2.0% |
|
|
7,417,243 |
2.59% |
17,500,000 |
24,917,243 |
3.4% |
|
|
1,273,587 |
0.44% |
1,500,000 |
2,773,587 |
0.4% |
|
|
905,405 |
0.32% |
1,000,000 |
1,905,405 |
0.3% |
|
|
100,000 |
0.03% |
500,000 |
600,000 |
0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) The number of Ordinary Shares presented in this table as being held or subscribed for by Directors refers to the number of Ordinary Shares held or subscribed for by them either personally or through a nominee.
(2) Assuming the Retail Offer is subscribed in full.
(3) Placing to be undertaken by
Subscription Agreements
The terms and conditions of each subscription agreement provide that each subscriber's investment is made at the Issue Price and will complete at the same time as the Placing, conditional on Admission and the approval of Shareholders of the Resolutions at the General Meeting.
General Meeting
The Fundraising and the issue of the New Ordinary Shares are conditional upon, among other things, the Resolutions being duly passed by Shareholders at the General Meeting.
The Circular, containing further details of the Fundraising and notice of the General Meeting to be held on or around
Admission, Settlement and Dealings
Application will be made to the London Stock Exchange for admission of the New Ordinary Shares to trading on AIM, being the market of that name operated by the London Stock Exchange ("Admission").
It is expected that admission of the New Ordinary Shares will take place on or around
In addition to the passing of certain Resolutions at the General Meeting, the Placing and Subscription, are conditional upon, inter alia, Admission becoming effective. The Placing is not subject to clawback from the Retail Offer.
Following Admission of the Placing Shares and the Subscription Shares and assuming the full take up of the Retail Offer, the Company will have 725,027,042 Ordinary Shares in issue. The New Ordinary Shares to be issued, when issued, will be fully paid and will rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of issue.
A further announcement will be made in relation to total voting rights in the Company's share capital following the allotment and issue of the New Ordinary Shares.
For the purposes of
Capitalised terms used in this announcement (this "Announcement") have the meanings given to them in the Launch Announcement, unless the context provides otherwise.
This Announcement should be read in conjunction with the full text of the Circular to be posted to Shareholders on
Enquiries:
|
GENinCode Plc |
www.genincode.com or via Walbrook PR |
|
|
|
|
|
|
|
Cavendish Capital Markets Limited (Nomad, Broker and Joint Bookrunner) |
Tel: +44 (0) 20 7220 0500 |
|
|
|
|
Oberon Capital (Joint Bookrunner)
|
Tel: +44 (0) 203 179 5300 |
|
Turner Pope Investments (TPI) Ltd (Joint Bookrunner) |
Tel: (0) 20 3657 0050 |
|
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or |
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE